(10:21 GMT) Alnylam Pharmaceuticals Price Target Cut to $470.00/Share From $510.00 by HC Wainwright & Co.
Dow Jones Newswires
Alnylam Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.
- Sources
- Dow Jones Newswires
- Markets
- Stocks
- Active symbols
- NASDAQ:ALNY
- Language
- English